{
  "ptid_time": "053_S_1044_2006-10-26",
  "img_path": "/data/qiuhui/data/adni/images/053_S_1044/2006-10-26/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 42,875 mm³, 42.8% above the reference mean. With a Z-score of 1.02 (84.5th percentile), this represents mild enlargement; hippocampal volume measures 6,310 mm³, 21.4% below the reference mean. With a Z-score of -2.14 (1.6th percentile), this represents significant atrophy; whole brain volume measures 1,046,500 mm³, 7.8% below the reference mean. With a Z-score of -1.10 (13.6th percentile), this represents mild atrophy; entorhinal cortex volume measures 3,120 mm³, 26.8% below the reference mean. With a Z-score of -1.86 (3.2th percentile), this represents moderate atrophy; fusiform gyrus volume measures 16,627 mm³, 16.5% below the reference mean. With a Z-score of -1.37 (8.5th percentile), this represents mild atrophy; middle temporal gyrus volume measures 18,343 mm³, 18.2% below the reference mean. With a Z-score of -1.50 (6.7th percentile), this represents mild atrophy. ",
  "text_data": "Age is 65.6 years. Gender is Male. Education: 13 years. Handedness: Right. Race: White. Medical history: Respiratory; Smoking; Malignancy; Major Surgical Procedures. MMSE: 25.0. Logical Memory: 4.0. APOEε4 alleles: 1.0. Biomarker levels: Amyloid beta: 594.20 pg/mL (mild reduced); Total tau: 483.70 pg/mL (profound elevated); Phosphorylated tau: 47.98 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant hippocampal atrophy (Z-score -2.14, 1.6th percentile) and moderate entorhinal cortex atrophy (Z-score -1.86, 3.2nd percentile), both strongly associated with Alzheimer's pathology. Elevated T-tau and P-tau, along with mildly reduced Aβ, further support Alzheimer's-related neurodegeneration. The MMSE score of 25 suggests mild cognitive impairment.  \n\n**Diagnosis:** **MCI (likely due to Alzheimer’s disease)**  \n**Confidence:** **High**  \n\n*(Note: The presence of significant biomarker and structural changes with only mild cognitive deficits aligns best with MCI, though progression to dementia is likely.)*",
  "timestamp": "2025-07-26T07:56:51.067735"
}